Conventional and Emerging MRI Biomarkers of Multiple Sclerosis

Timothy Reynold Lim1, Jerald Garvin Lim2, Yusuf Alibrahim1

  • 1Division of Neuroradiology, Department of Medical Imaging, Unity Health Toronto-St. Michael's Hospital, University of Toronto, 30 Bond St, Toronto, ON, Canada M5B 1W8.

Summary

The 2024 McDonald criteria enhance multiple sclerosis (MS) diagnosis using new MRI biomarkers like the central vein sign. These advancements improve accuracy, especially for atypical cases, aiding earlier and more precise patient management.